Detalles de la búsqueda
1.
Effectiveness and Safety of Retreatment with 177Lu-DOTATATE in Patients with Progressive Neuroendocrine Tumors: A Retrospective Real-World Study in the United States.
J Nucl Med
; 65(5): 746-752, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514088
2.
Targeted α-Emitter Therapy with 212Pb-DOTAMTATE for the Treatment of Metastatic SSTR-Expressing Neuroendocrine Tumors: First-in-Humans Dose-Escalation Clinical Trial.
J Nucl Med
; 63(9): 1326-1333, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34992153
3.
64Cu-DOTATATE PET/CT for Imaging Patients with Known or Suspected Somatostatin Receptor-Positive Neuroendocrine Tumors: Results of the First U.S. Prospective, Reader-Masked Clinical Trial.
J Nucl Med
; 61(6): 890-896, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31924723
Resultados
1 -
3
de 3
1
Próxima >
>>